Radiosynthesis of [2- 11C-carbonyl]dantrolene using [ 11C]phosgene for PET

Applied Radiation and Isotopes

Volumn 68, Issue 9, 2010, Pages 1715-1720

  Takada, Yuuki ^a,b   Ogawa, Masanao ^a,c   Suzuki, Hisashi ^a   Fukumura, Toshimitsu ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c 141 0032   (Japan)

Author keywords

2 11C carbonyl dantrolene; 11C phosgene; Positron emission tomography (PET)

Indexed keywords

[2- 11C-CARBONYL]DANTROLENE; [ 11C]PHOSGENE; AUTOMATED SYNTHESIS; BREAST CANCER RESISTANCE PROTEINS; MULTI-STEP; RADIOCHEMICAL PURITY; RADIOCHEMICAL YIELD; RADIOSYNTHESIS; SPECIFIC ACTIVITY;

ISOTOPES; RADIATION;

POSITRON EMISSION TOMOGRAPHY;

2 [2 [5 (4 NITROPHENYL)FURFURYLIDENE]HYDRAZINO]ACETAMIDE; [2 CARBONYL]DANTROLENE C 11; CARBON 11; DANTROLENE; ETHYL 2 [2 [5 (4 NITROPHENYL)FURFURYLIDENE]HYDRAZINO]ACETATE; PHOSGENE; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; CYCLOTRON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; ONE POT SYNTHESIS; OXIDATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIOACTIVITY; RADIOCHEMISTRY; RADIOSYNTHESIS; ROOM TEMPERATURE; SYNTHESIS; CHEMISTRY; METHODOLOGY;

CARBON RADIOISOTOPES; DANTROLENE; ISOTOPE LABELING; PHOSGENE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 78649327550     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2010.03.012     Document Type: Article

References (20)

1. Bart J., Hollema H., Groen H.J., de Vries E.G., Hendrikse N.H., Sleijfer D.T., Wegman T.D., Vaalburg W., van der Graaf W.T. The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumors. Eur. J. Cancer 2004, 40:2064-2070.
2. Borst P., Oude E.R. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 2002, 71:537-592.
3. Cotarca L., Eckert H. Phosgenations-A Handbook 2004, Wiley-VCH.
4. Dewitt S.H., Kiely J.S., Stankovic C.J., Schroeder M.C., Reynolds Cody D.M., Pavia M.R. "Diversomers": an approach to nonpeptide, nonoligomeric chemical diversity. Proc. Natl. Acad. Sci. USA 1993, 90:6909-6913.
5. 11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier. J. Med. Chem. 2009, 52:6073-6082.
6. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 1998, 95:15665-15670.
7. Enokizono J., Kusuhara H., Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol. Pharmacol. 2007, 72:967-975.
8. Enokizono J., Kusuhara H., Ose A., Schinkel A.H., Sugiyama Y. Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab. Dispos. 2008, 36:995-1002.
9. Fukumura T., Suzuki H., Mukai K., Zhang M.R., Yoshida Y., Nemoto K., Suzuki K. Development of versatile synthesis equipment for multiple production of PET radiopharmaceutical. J. Labelled Compd. Radiopharm. 2007, 50:s202.
10. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.
11. Hanessian S., Yang R.Y. Solution and solid phase synthesis of 5-alkoxyhydantoin libraries with a three-fold functional diversity. Tetrahedron Lett. 1996, 37:5835-5838.
12. Ishikawa T. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy. Adv. Drug Deliv. Rev. 2009, 61:1-2.
13. Ishiwata K., Kawamura K., Yanai K., Hendrikse N.H. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. J. Nucl. Med. 2007, 48:81-87.
14. 11C]gefitinib. Nucl. Med. Biol. 2009, 36:239-246.
15. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., Subcellular Schellens J.H. Localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001, 61:3458-3464.
16. 4 gas detection tube. Nucl. Med. Biol. 2010, 37:73-76.
17. 3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J. Med. Chem. 1999, 42:1872-1880.
18. 68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. J. Nucl. Med. 2005, 46:354-364.
19. Wilson L.J., Li M., Portlock D.E. Solid phase synthesis of 1-aminohydantoin libraries. Tetrahedron Lett. 1998, 39:5135-5138.
20. Zhang W., Mojsilovic-Petrovic J., Andrade M.F., Zhang H., Ball M., Stanimirovic D.B. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 2003, 17:2085-2087.